TherapeuticsMD
TXMD
$1.86
Share price
-0.53%
Change (1 day)
-47.31%
Change (1 year)
Categories
Operating Margin for TherapeuticsMD (TXMD)
Operating Margin as of April 2024 (TTM): 1.53%
According to TherapeuticsMD's latest financial reports and stock price the company's current Operating Margin is 1.53%. At the end of 2021 the company had an Operating Margin of -172.33%.
Operating Margin history for TherapeuticsMD from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -172.33% | -27.85% |
| 2020 | -238.84% | -25.31% |
| 2019 | -319.78% | -59.76% |
| 2018 | -794.68% | 71.75% |
| 2017 | -462.69% | -0.77% |
| 2016 | -466.27% | 10.25% |
| 2015 | -422.93% | 17.78% |
| 2014 | -359.09% | 22.38% |
| 2013 | -293.42% | -66.27% |
| 2012 | -869.95% | 41.38% |
| 2011 | -615.32% | -33.45% |
| 2010 | -924.61% | -94.06% |
| 2009 | -15,570.87% | |
| 2006 | 48.63% | 30.23% |
| 2005 | 37.34% | 18.04% |
| 2004 | 31.64% | -20.19% |
| 2003 | 39.64% | 13.74% |
| 2002 | 34.85% | 88.36% |
| 2001 | 18.50% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 34.61% | 2,162.09% | 🇺🇸 USA |
 AbbVie ABBV | 18.65% | 1,118.95% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -451.32% | -29,598.04% | 🇺🇸 USA |
 Royalty Pharma RPRX | 27.89% | 1,722.88% | 🇬🇧 UK |
 Lannett Company LCI | -43.36% | -2,933.99% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.